Skip to main content

Testosterone Undecanoate — Schering AG

This is a preview of subscription content, access via your institution.

Table I
Table II


  1. 1.

    Schering AG. Schering Gets Green Light for Nebido™ in Europe. Media Release: 8 Jul 2004. Available from URL:

  2. 2.

    Kamischke A, Nieschlag E, Venherm S, et al. Studies towards male contraception using a long acting testosterone ester: additive effects of gestagens. 11th International Congress of Endocrinology: 139, 29 Oct 2000

    Google Scholar 

  3. 3.

    Kamischke A, Venherm S, Plöger D, et al. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception. Journal of Clinical Endocrinology and Metabolism 86: 303–309, Jan 2001

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Kamischke A, Heuermann T, Krüger K, et al. An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations. Journal of Clinical Endocrinology and Metabolism 87: 530–539, Feb 2002

    PubMed  Article  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Testosterone Undecanoate — Schering AG. Drugs R D 5, 368–369 (2004).

Download citation


  • Levonorgestrel
  • Azoospermia
  • Norethisterone
  • Testosterone Deficiency
  • Testosterone Undecanoate